Nkarta reports first quarter 2024 financial results and corporate highlights

South san francisco, calif., may 09, 2024 (globe newswire) -- nkarta, inc. (nasdaq: nktx), a clinical-stage biopharmaceutical company developing engineered natural killer (nk) cell therapies, today reported financial results for the first quarter ended march 31, 2024.
NKTX Ratings Summary
NKTX Quant Ranking